Remifentanil은 흰쥐의 국소 허혈-재관류 모델에서 심근 보호 효과가 있는가? = Experimental Research Article : Dose remifentanil have a myocardial protective effect against a regional ischemia-reperfusion injury in an in vivo rat heart model?

다국어 초록 (Multilingual Abstract)

Background: It is known that some opioids protect the myocardial tissue from myocardial ischemia-reperfusion (I/R) injury. The aim of this study was to investigate whether remifentanil, at a clinically relevant concentration that`s during the peri-ischemic period, has a protective effect against a regional I/R injury in an in vivo rat heart model. Methods: Rats were subjected to 25 minutes of coronary artery occlusion and this was followed by 24 hours of reperfusion. A microcatheter was advanced into the left ventricle and the hemodynamic function was evaluated after 24 hours of reperfusion. The infarct size was determined by triphenyltetrazolium staining. The serum level of cardiac troponin-I (cTnI) was determined by ELISA (enzyme-linked immunosorbent assay). Results: Remifentanil administration during the peri-ischemic period didn`t show any identifiable protective effects for the hemodynamic function or to reduce the infarct size. In the control group, the peak rate of the ventricular pressure increase (+dP/dt(max)) (P<0.05) and the peak rate of the intraventricular pressure decline (-dP/dt(max) P<0.05) were significantly decreased as compared to those values for the sham group. In the remifentanil group, the +dP/dt(max) and -dP/dt(max) were not improved compared to those values of the control group. The infarct size was 45.6% of the area at risk in the control group, and the infarct size was reduced by administration of remifentanil to 43.2% in the remifentanil group. The I/R-induced serum level of cTn-I was not reduced by remifentanil infusion during the peri-ischemic period. Conclusions: Remifentanil, at a clinically relevant concentration that`s infused during the peri-ischemic period, has no myocardial protective effect after regional myocardial I/R injury in an in vivo rat heart model. (Korean J Anesthesiol 2009;57:190∼4)

참고문헌 (Reference)

1 Babuin L, "Troponin: the biomarker of choice for the detection of cardiac injury" 173 : 1191-1202, 2005

2 Mayfield KP, "Role of endogenous opioid peptides in the acute adaptation to hypoxia" 582 : 226-231, 1992

3 Bürkle H, "Remifentanil: a novel, short-acting, mu-opioid" 83 : 646-651, 1996

4 Yu CK, "Remifentanil preconditioning confers delayed cardioprotection in the rat" 99 : 632-638, 2007

5 Zhang Y, "Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors" 102 : 371-378, 2005

6 Zhang Y, "Remifentanil mimics cardioprotective effect of ischemic preconditioning via protein kinase C activation in open chest of rats" 26 : 546-550, 2005

7 Egan TD, "Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000" 13 : 449-455, 2000

8 Mangano DT, "Perioperative cardiac morbidity" 72 : 153-184, 1990

9 Schultz JE, "Opioids and cardioprotection" 89 : 123-137, 2001

10 Peart JN, "Opioid-induced preconditioning: recent advances and future perspectives" 42 : 211-218, 2005

11 Benedict PE, "Opiate drugs and delta-receptor-mediated myocardial protection" 100 : 357-360, 1999

12 Kato R, "Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists" 49 : 777-791, 2002

13 Badner NH, "Myocardial infarction after noncardiac surgery. [Clinical Investigations]" 88 : 572-578, 1998

14 Frässdorf J, "Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB" 101 : 934-941, 2005

15 Okubo S, "Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor" 287 : 1786-1791, 2004

16 Fukuda K, "Intravenous opioid anesthetics. In: Miller's anesthesia. 6th ed" Churchill Livingstone 379-437, 2005

17 Kato R, "Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and kATP channel linked mechanisms in rats" 84 : 204-214, 2000

18 Bell SP, "Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle" 36 : 2296-2302, 2000

19 Warltier DC, "Approaches to the prevention of perioperative myocardial ischemia" 92 : 253-259, 2000